Skip to content
Inciteful Med

Diagnosis and Testing for Giant Cell Arteritis

Last updated:

Diagnosing Giant Cell Arteritis involves blood tests, ultrasounds, and a temporal artery biopsy. However, the most critical step is starting steroid treatment immediately if GCA is suspected to prevent permanent vision loss, even before diagnostic tests are completed.

Key Takeaways

  • • Steroid treatment must be started immediately if GCA is suspected to prevent permanent vision loss, even before diagnostic tests are finished.
  • • Blood tests measuring ESR, CRP, and platelet counts identify systemic inflammation, though normal results do not completely rule out the disease.
  • • A temporal artery ultrasound can reveal a dark halo sign, which indicates swelling in the blood vessel wall.
  • • A temporal artery biopsy is the gold standard for diagnosis and should ideally be performed within 1 to 2 weeks of starting steroids.
  • • Advanced imaging like PET-CT or MRI is used when doctors suspect GCA is affecting the aorta or larger arteries in the limbs.

Important Note: You should never wait for these tests to be completed before starting treatment. If GCA is suspected, starting steroids immediately is the only way to protect your vision. [1][2]

Diagnosing Giant Cell Arteritis (GCA) requires a “puzzle-piece” approach, combining your clinical symptoms with blood work, specialized imaging, and sometimes a tissue sample [3][4]. Because the risk of vision loss is so high, doctors will often start treatment with high-dose steroids immediately—before all your test results are in [1][5].

Initial Blood Markers

Blood tests are usually the first step to look for signs of systemic inflammation.

  • ESR and CRP: The Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) are markers that are elevated in over 90% of GCA cases [6][7]. However, these tests are not perfect; they can be high due to other issues like infections or falsely influenced by other medications, and in about 3.5% of biopsy-proven GCA cases, they can actually be normal [8][3]. Doctors will always look at your “whole picture” rather than just the lab numbers.
  • Thrombocytosis: A high platelet count (thrombocytosis) is a strong predictor of GCA and often correlates with a positive biopsy [9][10].

Temporal Artery Ultrasound (TAUS)

Ultrasound has become a primary tool for diagnosing GCA because it is fast, non-invasive, and does not involve radiation [11][12].

  • The Halo Sign: The hallmark of GCA on an ultrasound is a dark “halo” surrounding the artery wall [11][13]. This halo is caused by swelling (edema) in the wall of the vessel [11][14].
  • Limitations: While very useful, a negative ultrasound cannot 100% rule out GCA, especially if the inflammation is “patchy” or located in deeper vessels [15][11].

Temporal Artery Biopsy (TABx)

The biopsy has long been considered the “gold standard” for diagnosis [3][16]. A surgeon removes a small piece of the artery from your temple to be examined under a microscope for signs of inflammation [16].

  • Skip Lesions: GCA inflammation can be “patchy,” meaning one section of the artery is inflamed while the section right next to it is healthy [16][17]. If the surgeon happens to remove a healthy section (a “skip lesion”), the biopsy will be negative even though you have the disease [16][17].
  • Timing: To get the most accurate result, the biopsy should ideally be performed within 1 to 2 weeks of starting steroid treatment [1][5].

Advanced Imaging for Extracranial GCA

When doctors suspect extracranial GCA—meaning the inflammation is in the aorta or the large arteries leading to your limbs—standard temple-based tests may not be enough [18][19].

  • PET-CT: This scan uses a small amount of radioactive sugar to highlight areas of high metabolic activity (inflammation) throughout the entire body [20][21]. It is especially helpful if your symptoms are vague or your biopsy was negative [21][18].
  • MRI and MRA: These provide detailed pictures of the blood vessel walls and can show structural damage, such as thickening or narrowing [22][23].

Frequently Asked Questions

Does a normal blood test mean I don't have Giant Cell Arteritis?
No, normal blood tests do not completely rule out Giant Cell Arteritis. While inflammatory markers like ESR and CRP are elevated in most cases, about 3.5% of biopsy-proven GCA patients have completely normal results.
Do I need a biopsy if my ultrasound shows a halo sign?
Your doctor may still recommend a temporal artery biopsy to confirm the diagnosis, as it is considered the gold standard. However, an ultrasound showing the hallmark halo sign often provides strong evidence to continue treatment.
Will taking steroids before my test ruin the biopsy results?
You should never delay steroid treatment while waiting for tests, as steroids are required to protect your vision. Temporal artery biopsies can still provide accurate results if performed within one to two weeks of starting steroid therapy.
Why might a temporal artery biopsy come back negative if I actually have GCA?
GCA inflammation can be patchy, meaning healthy tissue sits right next to inflamed tissue. If the surgeon accidentally removes a healthy section of the artery, known as a skip lesion, the biopsy will show a negative result despite the disease being present.
What tests are used if inflammation is in my larger arteries rather than my head?
If your doctor suspects extracranial GCA in your aorta or limbs, they may use advanced imaging like a PET-CT scan, MRI, or MRA. These scans can highlight inflammation and structural damage in larger blood vessels throughout your body.

Questions for Your Doctor

  • • My blood tests (ESR/CRP) were normal—does this completely rule out GCA, or do we need further imaging?
  • • If the temporal artery ultrasound showed a 'halo sign,' is a biopsy still necessary for my diagnosis?
  • • Since I’ve already started steroids, how long do we have before the biopsy or PET scan becomes less accurate?
  • • Should we perform an imaging test like a PET-CT to check for inflammation in my aorta or other large vessels?
  • • If the biopsy comes back negative but my symptoms persist, what is our next diagnostic step?

Questions for You

  • • Did your doctor tell you to start taking steroids immediately, even before your tests were scheduled?
  • • Have you noticed any new pain or cramping in your arms or legs, which might suggest the inflammation is in your larger arteries?
  • • Were you fasting before your PET scan, and did you tell the imaging center you are taking steroids?
  • • How long have you been experiencing symptoms like headaches or jaw pain before seeking medical help?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Orbital MRI Findings in a Patient With Giant Cell Arteritis (GCA): A Case Report.

    Alhawiti S, AlSulaim T

    Cureus 2023; (15(11)):e49507 doi:10.7759/cureus.49507.

    PMID: 38152789
  2. 2

    Unilateral Central Retinal Artery Occlusion Revealing Giant Cell Arteritis: A Case Report.

    Lazaar H, Moumni A, Aziz A, et al.

    Cureus 2025; (17(3)):e80452 doi:10.7759/cureus.80452.

    PMID: 40225509
  3. 3

    Clinical Diagnosis of Temporal Arteritis With Seronegative and Negative Biopsy Studies.

    Bayas A, Carranza O, Swerdloff MA

    Cureus 2022; (14(11)):e31011 doi:10.7759/cureus.31011.

    PMID: 36475126
  4. 4

    Ultrasound, PET/CT or temporal artery biopsy for giant cell arteritis? A prospective diagnostic accuracy study (the GAME-study).

    Hansen MS, Terslev L, Døhn UM, et al.

    Acta ophthalmologica 2026; doi:10.1111/aos.70114.

    PMID: 41793320
  5. 5

    Lower ocular pulse amplitude with dynamic contour tonometry is associated with biopsy-proven giant cell arteritis.

    Ing E, Pagnoux C, Tyndel F, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(3)):215-221 doi:10.1016/j.jcjo.2017.10.027.

    PMID: 29784156
  6. 6

    Is Erythrocyte Sedimentation Rate Necessary for the Initial Diagnosis of Giant Cell Arteritis?

    Hansen MS, Klefter ON, Terslev L, et al.

    Life (Basel, Switzerland) 2023; (13(3)) doi:10.3390/life13030693.

    PMID: 36983848
  7. 7

    Lessons of the month 4: Giant cell arteritis with normal inflammatory markers and isolated oculomotor nerve palsy.

    Walters B, Lazic D, Ahmed A, Yiin G

    Clinical medicine (London, England) 2020; (20(2)):224-226 doi:10.7861/clinmed.2019-0504.

    PMID: 32188666
  8. 8

    Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot.

    Currier CE, Bays AM, Thomason JL

    Rheumatology international 2025; (45(8)):175 doi:10.1007/s00296-025-05930-3.

    PMID: 40682608
  9. 9

    Full blood count as an ancillary test to support the diagnosis of giant cell arteritis.

    Oh LJ, Wong E, Andrici J, et al.

    Internal medicine journal 2018; (48(4)):408-413 doi:10.1111/imj.13713.

    PMID: 29236347
  10. 10

    Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.

    Grossman C, Barshack I, Koren-Morag N, et al.

    Clinical rheumatology 2016; (35(7)):1817-22 doi:10.1007/s10067-016-3221-1.

    PMID: 26925851
  11. 11

    Evolution of ultrasound in giant cell arteritis.

    Kirby C, Flood R, Mullan R, et al.

    Frontiers in medicine 2022; (9()):981659 doi:10.3389/fmed.2022.981659.

    PMID: 36262280
  12. 12

    Halo Sign on Temporal Artery Ultrasound Aids in Prompt Diagnosis of Giant Cell Arteritis.

    Laszlofy L, Bardoczi A, Husvethova D, et al.

    Methodist DeBakey cardiovascular journal 2025; (21(1)):100-105 doi:10.14797/mdcvj.1635.

    PMID: 41112312
  13. 13

    [Contribution of Doppler ultrasound for the diagnosis of giant cell arteritis].

    Rinagel M, Chatelus E, Arnaud L, Jousse-Joulin S

    Presse medicale (Paris, France : 1983) 2019; (48(9)):941-947 doi:10.1016/j.lpm.2019.06.004.

    PMID: 31327543
  14. 14

    Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis.

    Pouncey AL, Yeldham G, Magan T, et al.

    The Cochrane database of systematic reviews 2024; (2()):CD013199 doi:10.1002/14651858.CD013199.pub2.

    PMID: 38323659
  15. 15

    A Diagnostic Headache.

    Glynn T, Leech MT, Goergen SK, et al.

    The Medical journal of Australia 2026; (224(3)):e70151 doi:10.5694/mja2.70151.

    PMID: 41772926
  16. 16

    Efficacy of bilateral temporal artery biopsies and sectioning of the entire block of tissue for the diagnosis of temporal arteritis.

    Agostino A, Farmer J, Blanco P, et al.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2022; (59()):107425 doi:10.1016/j.carpath.2022.107425.

    PMID: 35346862
  17. 17

    Giant cell arteritis: A case report and review of literature.

    Crain MA, Lakhani DA, Winkler L, et al.

    Radiology case reports 2021; (16(12)):3734-3738 doi:10.1016/j.radcr.2021.08.072.

    PMID: 34630809
  18. 18

    Usefulness of 18F-FDG PET-CT for assessing large-vessel involvement in patients with suspected giant cell arteritis and negative temporal artery biopsy.

    Narváez J, Estrada P, Vidal-Montal P, et al.

    Arthritis research & therapy 2024; (26(1)):13 doi:10.1186/s13075-023-03254-w.

    PMID: 38172907
  19. 19

    Treatment-Resistant Arterial Hypertension Revealing Giant Cell Arteritis: A Case Report.

    Yassir DL, Moudatir PM, Echchilali PK, El Kabli PH

    The American journal of medicine 2026; doi:10.1016/j.amjmed.2026.02.015.

    PMID: 41791692
  20. 20

    Role and potential of 18F-fluorodeoxyglucose-positron emission tomography-computed tomography in large-vessel vasculitis: a comprehensive review.

    Collada-Carrasco J, Gómez-León N, Castillo-Morales V, et al.

    Frontiers in medicine 2024; (11()):1432865 doi:10.3389/fmed.2024.1432865.

    PMID: 39170047
  21. 21

    Bilateral Vertebral Artery Vasculitis-A Rare Manifestation of Giant Cell Arteritis and a Difficult Diagnosis Made Possible by 2-[18F]FDG PET/CT.

    Justesen ND, Hansen MS, Jensen MR, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(5)) doi:10.3390/diagnostics11050879.

    PMID: 34069137
  22. 22

    Multimodality Imaging in Cranial Giant Cell Arteritis: First Experience with High-Resolution T1-Weighted 3D Black Blood without Contrast Enhancement Magnetic Resonance Imaging.

    Brittain JM, Hansen MS, Carlsen JF, et al.

    Diagnostics (Basel, Switzerland) 2023; (14(1)) doi:10.3390/diagnostics14010081.

    PMID: 38201390
  23. 23

    The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.

    Berger CT, Sommer G, Aschwanden M, et al.

    Swiss medical weekly 2018; (148()):w14661.

    PMID: 30141518

This page provides educational information about diagnostic tests for Giant Cell Arteritis. Always consult your doctor immediately if you suspect GCA, as prompt treatment is crucial to prevent permanent vision loss.

Stay up to date

Get notified when new research about Giant cell arteritis is published.

No spam. Unsubscribe anytime.